SUMMARY A six week course of cimetidine (1 g/day) healed peptic ulcers in 20 of 23 patients (14 with duodenal ulcer, nine with gastric ulcer). Reduction of basal acid output by 73% and peak acid output by 36% led to a rise in concentrations of intragastric aerobic bacteria and nitrate-reducing bacteria. While the mean intragastric concentration of nitrate was unchanged by treatment, there were statistically significant rises in nitrite and N-nitrosamine concentrations. The conversion from nitrates to nitrites was closely related to the occurrence of nitrate-reducing bacteria. In three patients the intragastric milieu had returned to normal two months after cimetidine treatment had been discontinued. Mean nitrite and N-nitrosamine concentrations did not return to pre-treatment levels in the group of eight patients who remained on maintenance cimetidine (0.4 g at night-time) for three months after the full dose treatment. This study shows that cimetidine treatment can create an intragastric milieu resembling that of atrophic gastritis. Large scale and long-term studies are necessary to establish whether these findings have any clinical significance.
Cimetidine is effective in the treatment of peptic ulcers; as a result it is widely used, and is increasingly prescribed even in patients with no specific diagnosis. Some minor adverse effects have been described1 2 and there have been anecdotal reports about cimetidine delaying the diagnosis of gastric cancer.?5 The most serious objection to the drug, however, is the suggestion that long-term use might lead to malignant transformation of the gastric mucosa.A There is an increased incidence of gastric dysplasia and gastric cancer in patients with atrophic gastritis with or without pernicious anaemia, and after gastric resection.7-1U Most of these patients have hypochlorhydria or achlorhydria, and intragastric bacterial overgrowth. Some of the intragastric bacteria are able to convert endo-and exogenous nitrates to nitrites, leading potentially to the synthesis of N-nitrosamines. These compounds are carcinogenic in experimental animals and could contribute to the development of malignancy in atrophic gastritis."' 12 The present study was undertaken to see whether acid reduction by short-term and maintenance treatment with cimetidine can induce intragastric bacterial overgrowth with the formation of intraluminal nitrites and N-nitrosamines.13
Methods

PATIENTS
Twenty-three patients with endoscopically proven peptic ulcers were admitted to the study, which had been approved by the Clinical Investigation Panel at The Middlesex Hospital. They were 18 men and five women; mean age 49 years, mean duration of ulcer disease six years; 15 patients were smokers and eight non-smokers; 14 had duodenal ulcers, nine gastric ulcers. In three of the patients with gastric ulcers, the ulcers were situated in the pre-pyloric region. Fourteen patients had never been treated for peptic ulcer disease; nine had previously received cimetidine but in seven at least 12 9.4 with 5% borax buffer. The sample was deproteinised using zinc acetate in acetic acid and potassium ferrocyanide solution.14 Alumina cream15 was used to remove the colour from the gastric juice, and nitrite was measured by means of the diazo compound formed between sulphanilic acid and N-1-naphthylethylene diamine di-HC1.11 Nitrate was determined after conversion to nitrite by incubating the deproteinised, decolourised gastric juice with a bacterial suspension of E. coli having high nitrate reductase activity. Nitrate-reducing bacteria 0.5 ml of gastric juice was inoculated into 4.5 ml glycerol broth and frozen. Samples were stored at -20°C until bacteriological studies were carried out. Nitrate reducing activity was assessed by the method of Cowan and Steel, 16 and the number of nitrate-reducing organisms was obtained by reference to 'mean probable number' tables. 17 N-nitroso-compounds Sulphamic acid was added at a concentration of 0.5% wv to the residue of about 10 ml gastric juice, to prevent nitrosation as an artefact during storage. N-nitroso-compounds were extracted into ethyl-acetate from the acid milieu; thus any such compounds with a basic function are not included in the extraction. Nnitrosamines and N-nitrosamides were determined by the group selective procedures of Walters et al. 18 in which such compounds are denitrosated selectively to nitric oxide for measurement using a chemiluminescence analyser. All types of N-nitrosocompounds have been found to respond to this procedure. Of the compounds potentially formed from nitrite and nitrate in a biological matrix only nitrolic acids and S-nitrothiols have also been found to yield nitric oxide under the same conditions as N-nitroso-compounds.
Gastric secretion tests Gastric secretion tests were performed by standard technique.19 Small amounts of gastric juice were used to estimate the pH to the nearest half unit by pH-paper (Merck). Basal secretion was measured during four 15-minute periods and the maximal secretion for another hour after an intramuscular injection of pentagastrin (6 ug/kg body weight). Gastric There was a close correlation between bacterial counts and basal pH (r=0.822, p<0.001) and with BAO (r=0.664, p<0.001) but no correlation with PAO (r=0 402, p>0.05).
The rise in concentration of total aerobic bacteria was paralleled by a significant rise in the number of nitrate-reducing bacteria ( Table 1 ). The correlation between total bacteria/ml and those capable of nitrate-reduction was significant (r=0.631, p<0.01) (Fig. 1) . The mean concentration of nitrates did not fall significantly during treatment, but there was a significant rise for nitrites in the total group of patients; the rise in the group of patients with gastric ulcers was not significant (Table 2) .
There was a significant correlation between the concentration of nitrate-reducing bacteria and the ratio of nitrites to the total of nitrates plus nitrites (Fig. 2) . Treatment also induced a significant increase in the N-nitrosamine concentrations for the total patient group and for the subgroup of patients with gastric ulcers; the rise in the subgroup of patients with duodenal ulcers was not significant ( Table 2) .
MAINTENANCE TREATMENT
Complete gastric secretion tests were not repeated in the 11 patients given any maintenance treatment; instead, the pH of a basal specimen of gastric juice was measured, and specimens were prepared for microbiological and biochemical analyses as described above.
In the three patients in whom maintenance treatment had been discontinued two months before re-examination (group A), the pH, bacterial concentrations, and levels for nitrites had returned to pre-treatment values, but two nitrosamine-levels were still raised (52 and 120 ,ug/l as NN pyrrol respectively). In the eight patients on three months' maintenance treatment (group B), the mean basal pH had fallen from 6.7±0.4 to 4.5±0.9 (p<002). Mean counts of nitrate-reducing bacteria (Fig. 3a) and concentrations of nitrate, nitrite, (Fig. 3b) and N-nitrosamines (Fig. 3c) were not, however, statistically significantly different from those after full dose treatment. 
Discussion
This study confirms that cimetidine is a potent inhibitor of basal and stimulated gastric acid output; the ulcer healing rate of 87% after treatment with 1 g/day for six weeks is comparable with other reports. Parallel to the reduction in acid output, we showed a marked alteration of the intragastric milieu. There was a significant rise in bacterial concentrations; some of the bacterial species were capable of reducing nitrates to nitrites, and we found statistically significant increases in nitrite and Nnitrosamine concentrations after short-term treatment.
Our samples were taken in the morning, in the *A. Nitrate-reducrig bacteria Lag10 /ml 7 8 Fig 10 Full dose treatment with cimetidine is usually given for short courses. Our results in a small number of patients have not contraindicated such use with good clinical indications. Many patients are now prescribed low dose maintenance treatment with cimetidine. It is of concern that the mean N-nitrosamine levels remained raised in this study after three months' maintenance treatment at lower dosage, and even two months after the end of treatment in two patients. These aspects require longer term and larger scale studies before any clinical conclusions can be attempted. 
